2.3. Analysis.
Comparison 2 Leukotriene Receptor Antagonists (LTRA) + ICS vs. DOUBLE dose of ICS in SYMPTOMATIC PATIENTS, Outcome 3 Patients with 1 or more exacerbations requiring hospital admission at LICENSED DOSES.
Comparison 2 Leukotriene Receptor Antagonists (LTRA) + ICS vs. DOUBLE dose of ICS in SYMPTOMATIC PATIENTS, Outcome 3 Patients with 1 or more exacerbations requiring hospital admission at LICENSED DOSES.